title: Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours.
abstract: A residual retroperitoneal mass containing only fibrosis and necrosis is present in 40-52% of patients with advanced testicular germ cell tumours after chemotherapy. The biological nature and genetic characteristics of the stromal cells in these residual masses have not been adequately investigated. Laser-microdissected stromal cells from 27 patients who underwent retroperitoneal lymph node dissection after chemotherapy for metastatic testicular germ cell tumour were analysed. Allelic loss in the stromal cells of fibrosis was present at one or more of the ten microsatellite DNA loci examined in 23 (85%) of the cases. Chromosome arm 12p anomalies, the hallmark of germ cell neoplasia, were present in nine (33%) cases. The high frequency of allelic losses and chromosome arm 12p anomalies in the stromal cells from residual retroperitoneal fibrous masses after chemotherapy for testicular germ cell tumours suggests that the stromal cells are derived from the same tumour progenitor cells as the pre-existing metastatic germ cell tumour.
authors.affiliation: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. lcheng@iupui.edu
authors.forename: L
authors.initials: L
authors.lastname: Cheng
authors.forename: S
authors.initials: S
authors.lastname: Zhang
authors.forename: M
authors.initials: M
authors.lastname: Wang
authors.forename: D D
authors.initials: DD
authors.lastname: Davidson
authors.forename: M J
authors.initials: MJ
authors.lastname: Morton
authors.forename: J
authors.initials: J
authors.lastname: Huang
authors.forename: S
authors.initials: S
authors.lastname: Zheng
authors.forename: T D
authors.initials: TD
authors.lastname: Jones
authors.forename: S D
authors.initials: SD
authors.lastname: Beck
authors.forename: R S
authors.initials: RS
authors.lastname: Foster
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002869:Chromosome Aberrations; D003131:Combined Modality Therapy; D005355:Fibrosis; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D019656:Loss of Heterozygosity; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D042282:Microdissection; D018895:Microsatellite Repeats / Q000235:genetics; D018613:Microscopy, Confocal; D009336:Necrosis; D009373:Neoplasms, Germ Cell and Embryonal / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D009919:Orchiectomy; D017154:Stromal Cells / Q000378:metabolism / Q000473:pathology*; D013736:Testicular Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy